| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/30/1992 | CN1018453B Process for preparation of new diaryl compounds |
| 09/30/1992 | CN1018452B Process for preparing azacycloalkane derivatives |
| 09/30/1992 | CA2108041A1 Targeted drug delivery via mixed phosphate derivatives |
| 09/30/1992 | CA2107365A1 New non-anticoagulant heparin derivatives |
| 09/30/1992 | CA2107362A1 New non-anticoagulant heparin derivatives |
| 09/30/1992 | CA2107222A1 Fat substitute compositions having reduced laxative effects |
| 09/30/1992 | CA2107218A1 Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors |
| 09/30/1992 | CA2062406A1 Ganglioside gm3 analogs |
| 09/30/1992 | CA2062369A1 Thioglycoside analogs of gangliosides |
| 09/29/1992 | WO1992017507A1 Anticoagulants and processes for preparing such |
| 09/29/1992 | WO1992017446A2 Pyridazinone acetic acids aldose reductase inhibitors |
| 09/29/1992 | US5151545 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents |
| 09/29/1992 | US5151534 Antiallergens, antiinflammatory agents or skin disorders |
| 09/29/1992 | US5151513 N-heterocyclic alcohol derivatives |
| 09/29/1992 | US5151449 N-alpha-dimethyl-N-2-propynylbenzene-ethanamine for Parkinson disease |
| 09/29/1992 | US5151448 Method for treating premature ejaculation |
| 09/29/1992 | US5151445 Trypanosoma |
| 09/29/1992 | US5151444 Ocular hypotensive agents |
| 09/29/1992 | US5151442 Cardiovascular disorders and nervous system disorders |
| 09/29/1992 | US5151440 Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines |
| 09/29/1992 | US5151437 Compounds for treatment of central nervous system disorders |
| 09/29/1992 | US5151435 Angiotensin ii antagonists incorporating an indole or dihydroindole |
| 09/29/1992 | US5151434 Controlled-release composition and the preparation thereof |
| 09/29/1992 | US5151432 Substituted amino acid compounds |
| 09/29/1992 | US5151431 4,5-dihydro-6H-imidazo[4,5,1-ij]quinolin-6-one-6-oxime-O-sulfonic acid derivatives useful for treating hypertension or edema |
| 09/29/1992 | US5151427 Anthelminitics |
| 09/29/1992 | US5151425 Method of and composition for treating inflammation and the immunological response thereto |
| 09/29/1992 | US5151423 Antiinflammatory agents or antiallergens |
| 09/29/1992 | US5151419 Neuroleptic agents |
| 09/29/1992 | US5151418 Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides |
| 09/29/1992 | US5151417 3-substituted vinyl cephalosporin derivatives |
| 09/29/1992 | US5151415 Acetylsalicylic acid for treatment of viral tumors such as planter's warts |
| 09/29/1992 | US5151414 Hypotensive agents |
| 09/29/1992 | US5151360 Antitumor agents or anticarcinogenic agents |
| 09/29/1992 | US5151352 Culture of Streptomyces to produce clerodane diterpene derivative |
| 09/29/1992 | US5151274 Calcium and trace mineral supplements |
| 09/29/1992 | US5151268 DNA cloning vectors for genetic engineering |
| 09/29/1992 | US5150718 Method of contraception |
| 09/29/1992 | CA2107124A1 Anticoagulants and processes for preparing such |
| 09/29/1992 | CA2107104A1 Pyridazinone acetic acids as aldose reductase inhibitors |
| 09/29/1992 | CA2064384A1 6-heterocyclic-4-amino-1,3,4,5- tetrahydrobenz [cd] indoles |
| 09/29/1992 | CA2064363A1 6-heterocyclic-4-amino-1,2,2a,3,4,5- hexahydrobenz ¬cd| indoles |
| 09/29/1992 | CA2064358A1 Use of 4, 9, 11-trienic steroids in compositions for administration to turkeys |
| 09/29/1992 | CA1308116C Triglyceride quaternary ammonium compounds, their preparation and use |
| 09/29/1992 | CA1308110C Cyclic anti-inflammatory derivatives of di-tert-butylphenolcompounds |
| 09/29/1992 | CA1308107C Monosulfactams |
| 09/29/1992 | CA1308106C Derivatives of 4-aminoquinoline and their use as medicaments |
| 09/29/1992 | CA1308104C Hydrate form endo-4-amino-5-chloro-2-methoxy -n-[1-azabicyclo- (3,3,1)-non-4-yl]-benzamide hydrochloride |
| 09/29/1992 | CA1308103C 1,4-disubstituted piperazine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 09/29/1992 | CA1308102C Water soluble camptothecin analogs |
| 09/29/1992 | CA1308095C 11.beta.-ARYLESTRADINENES, THE PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME |
| 09/29/1992 | CA1308028C Pharmaceutical compositions for treating adrenoleukodystrophy |
| 09/29/1992 | CA1308027C Stable prostaglandin-containing composition |
| 09/29/1992 | CA1308026C Control release composition containing zidovudine |
| 09/29/1992 | CA1308024C Vitamin-containing granules and production thereof |
| 09/28/1992 | WO1992017477A1 New active compounds |
| 09/28/1992 | WO1992017454A1 Bis-naphthalimides containing amide and thioamide linkers as anticancer agents |
| 09/28/1992 | CA2106996A1 Bis-naphthalimides containing amide and thioamide linkers as anticancer agents |
| 09/28/1992 | CA2106880A1 Active compounds |
| 09/28/1992 | CA2064126A1 Compounds, named the "leustroducins", their preparation and their therapeutic uses |
| 09/28/1992 | CA2063941A1 Use of 4-amino-1-(2-pyridyl)piperidines for the preparation of a medicament for the treatment and prophylaxis of conditions deriving from disorders of the serotoninergic systems mediated by 5-ht3 receptors |
| 09/28/1992 | CA2063909A1 Inhibitors of hiv-1 reverse transcriptase |
| 09/27/1992 | WO1992017471A1 Chromans and thiochromans with heteroarylethynyl substituents at the 7-position having retinoid-like biological activity |
| 09/27/1992 | WO1992017449A1 Stereoselective preparation of substituted piperidines |
| 09/27/1992 | WO1992017426A2 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
| 09/27/1992 | WO1992017183A1 Sequential dosing of antifungal and antiinflammatory compositions |
| 09/27/1992 | CA2107237A1 Sequential dosing of antifungal and antiinflammatory compositions |
| 09/27/1992 | CA2105379A1 Chromans and thiochromans with heteroarylethynyl substituents at the 7-position having retinoid-like biological activity |
| 09/27/1992 | CA2105158A1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
| 09/27/1992 | CA2063866A1 Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| 09/27/1992 | CA2063850A1 Sulfated tocopheryl oligosaccharides and antiviral agents including the same as active ingredients |
| 09/27/1992 | CA2063170A1 Indole derivatives, preparation processes and medicinal products containing them |
| 09/27/1992 | CA2061661A1 N-acyl-.alpha.-amino derivatives |
| 09/26/1992 | WO1992016550A1 Organosulphur compounds useful for the treatment of glaucoma |
| 09/26/1992 | CA2106860A1 Organosulphur compounds useful for the treatment of glaucoma |
| 09/26/1992 | CA2063885A1 New heterocyclic alkyl amides, process for their preparation and pharmaceutical compositions containing them |
| 09/26/1992 | CA2063784A1 Ingestible material |
| 09/26/1992 | CA2063773A1 Anti-platelet aggregating agent |
| 09/26/1992 | CA2063742A1 Angiotensin ii antagonists incorporating a nitrogen containing six membered ring heterocycle |
| 09/26/1992 | CA2063172A1 4-aryl-thiazole or imidazole derivatives |
| 09/26/1992 | CA2061477A1 Analgesic composition containing beta-carotene |
| 09/24/1992 | WO1992016539A1 Novel platinum(ii) complex and processes for preparing the same |
| 09/24/1992 | WO1992016485A1 New phenol ethers, process for producing the same and medicaments containing these compounds |
| 09/24/1992 | CA2106687A1 Phenol ethers, processes for their preparation and medicaments which contain these compounds |
| 09/23/1992 | WO1992016513A1 New compounds for use in the treatment of cancer |
| 09/23/1992 | EP0505322A1 Aminoguanidines |
| 09/23/1992 | EP0505226A1 Active oxygen scavenger |
| 09/23/1992 | EP0505220A1 New compounds for use in the treatment of cancer |
| 09/23/1992 | EP0505181A1 Use of 3'-azido-2',3'-dideoxyguanosine for the treatment of hepatitis B |
| 09/23/1992 | EP0505180A1 High-content ibuprofen lysinate pharmaceutical formulation |
| 09/23/1992 | EP0505135A2 Cholesterol lowering agents and antifungal agents |
| 09/23/1992 | EP0505122A1 Alpha, alpha-dialkylbenzyl derivatives |
| 09/23/1992 | EP0505111A2 Angiotensin II antagonists incorporating a substituted imidazo (1,2-b)(1,2,4) triazole |
| 09/23/1992 | EP0505098A1 Imidazole derivatives bearing acidic functional groups as angiotensin II antagonists |
| 09/23/1992 | EP0505097A2 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 09/23/1992 | EP0505095A2 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 09/23/1992 | EP0505058A1 Thienopyridine derivatives and pharmaceutical compositions containing them |
| 09/23/1992 | EP0505047A1 Rearranged taxol compounds and method of using in testing of in vivo activity |
| 09/23/1992 | EP0505017A2 Selective phenylation of 5-hydroxy-beta-carbolin-derivatives |
| 09/23/1992 | EP0504871A1 Aranorosinol-A and Aranorosinol-B, a process for their production and their use |